News
The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...
When will the Miami Dolphins trade Jalen Ramsey? What teams could trade for Ramsey? Get your answers on Ramsey here.
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
16h
Clinical Trials Arena on MSNFDA clears Grifols’ application for dry eye disease treatmentThe US Food and Drug Administration (FDA) has cleared Grifols' investigational new drug (IND) application to initiate a Phase ...
Samsung Galaxy Z Flip 6 gets a massive price cut on Amazon, now under Rs 76,000 with discounts and bank offers—plus extra ...
Homebound' by Neeraj Ghaywan gets a 9-minute ovation at Cannes 2025 as he reunites with jury member Payal Kapadia.
Patients with glaucoma or dry eye disease are likely to have additional systemic conditions that makes self-administration of drops difficult.
U.S. stocks opened lower on Wednesday morning as the selloff in longer-term Treasurys picked up steam. Investors feared President Donald Trump's new tax bill could worsen the country’s deficit ...
The Dow Jones Industrial Average extended its decline on Wednesday, soon after the results of a $16 billion sale of 20-year Treasury bonds came in. The Dow was down by more than 600 points, or 1.4%, ...
From the best nasal sprays to putting eye drops in the refrigerator - Dr. Eric Chen, Chief of Allergy/Immunology for Kaiser in Antioch, shares tips to relieve spring time allergies.
Grifols received FDA clearance to begin a Phase II trial of GRF312, an immunoglobulin eye drop for dry eye disease, aiming to ...
LUMIFY eye drops were initially introduced by Bausch + Lomb in 2018 and remain the only OTC redness relievers that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results